fully cashed up biotech, page-6

Hey guys

I'm out of BOS for the time being. Still believe in the potential of the technology but the timeframe for commercialisation seems to be slipping again - doubt we will see anything of substance on this front this year.

So took the funds and put them elsewhere for the time being. Will still be watching and may get back in when something concrete happens - in all honesty, they are yet to kick any goals, and perhaps not even a point? Have enough cash to get them through at least 07, which is important, but I still have my doubts on the corporate abilities of the board/management (seems like they are all tech boffins). At first they went for a focused development strategy in limited fields...then when this wasn't working they've gone for somewhat of a scattergun approach looking at all sorts of different stuff. I expect their technical people are perhaps now too thinly spread? Hence nothing on the development front and seemingly endless delays in reaching milestones.

Overall very disappointed with the performance when the technology appears to be a ball tearer.